Donal O'Connor - Nov 22, 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 22, 2022
Transactions value $
-$105,000
Form type
4
Date filed
11/23/2022, 05:57 PM
Previous filing
May 19, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Disposed to Issuer -$105K -10K -18.56% $10.50 43.9K Nov 22, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's Dutch auction tender offer for up to $95 million of its ordinary shares.